Skip to main content

Table 2 Procedural related complications during and after PDT differentiated by treatment group

From: Percutaneous dilatational tracheotomy in high-risk ICU patients

Complication

(I) Heparin (prophylactic dosage)

(n = 101)

(II) Heparin (therapeutic dosage)

(n = 131)

(III) Aspirin and/or P2Y12 receptor inhibitor with heparin (prophylactic or therapeutic dosage) except for triple therapy (n = 290)

(IV) DAPT with heparin (therapeutic dosage) (triple therapy)

(n = 149)

Overall

(n = 671)

P-value

Intraprocedural bleeding n (%)

5 (5)

4 (3)

13 (4)

4 (3)

26 (4)

ns

Postprocedural bleeding n (%)

9 (9)

9 (7)

19 (7)

11 (7)

48 (7)

ns

Intra-/postproceddural bleeding n (%)

14 (14)

13 (10)

32 (11)

15 (10)

74 (11)

ns

Intra-/postproceddural pneumothorax n (%)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

ns

Intraprocedural accidental cannula dislocation n (%)

3 (3)

7 (5)

2 (1)

1 (1)

13 (2)

ns

Intraprocedural accidental tubus dislocation n (%)

0 (0)

2 (2)

4 (1)

2 (1)

8 (1)

ns

Postprocedural tracheocutaneous fistula n (%)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

ns

Postprocedural infection n (%)

1 (1)

0 (0)

4 (1)

0 (0)

5 (1)

ns

Postprocedural granulation at the tracheostoma n (%)

1 (1)

2 (2)

0 (0)

1 (1)

4 (1)

ns

Postprocedural wound healing n (%)

1 (1)

0 (0)

1 (1)

0 (0)

2 (0)

ns

Intraprocedural O2 desaturation n (%)

2 (2)

1 (1)

7 (2)

0 (0)

10 (1)

ns

Intraprocedural hypotension n (%)

5 (5)

3 (2)

17 (6)

5 (3)

30 (4)

ns

Intraprocedural cardiac arrhythmia n (%)

1 (1)

0 (0)

0 (0)

0 (0)

1 (0)

ns

Intraprocedural fracture of tracheal cartilage n (%)

1 (1)

9 (7)

13 (4)

6 (4)

29 (4)

ns

Intraprocedural resuscitation n (%)

1 (1)

0 (0)

4 (1)

0 (0)

5 (1)

ns

Intra/postprocedural death n (%)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

ns

  1. p-values < 0.05 were considered as significant; ns non-significant